Recent Advances in the Management of Metastatic Prostate Cancer

Management of metastatic prostate cancer has undergone a revolution over the past decade with the introduction of several novel agents and repurposing of others. Several clinical trials reported improved outcomes with the intensification of androgen deprivation therapy by the addition of docetaxel c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JCO oncology practice 2022-01, Vol.18 (1), p.45-55
Hauptverfasser:	Sayegh, Nicolas, Swami, Umang, Agarwal, Neeraj
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Humans Male Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use Prostatic Neoplasms, Castration-Resistant - drug therapy United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!